A Phase 2, Open-Label, Multiple-Dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 inPediatric Subjects with Congenital Adrenal Hyperplasia

Project: Research project

Project Details

Description

A Phase 2, Open-Label, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects with Congenital Adrenal Hyperplasia
StatusActive
Effective start/end date5/28/195/31/24

Funding

  • Neurocrine Biosciences, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.